a.okwuosa
Submits third-party assay reports on material purchased directly. Based in Beirut.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
97.87%
n=5
Suppliers covered
5
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042409 | MK-677 (Ibutamoren mesylate) | SWB | SWB-2605-B4738 | Medutest | 2026-Q2 | 99.32 | 2.99 | 94.9 | Laboratory-retained | 1 | FAIL |
| AX-2026-041226 | Thymulin | WWB | WWB-2602-S2129 | Janoshik | 2026-Q2 | 99.36 | 4.19 | 88.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043490 | Leuprolide | WXT | WXT-2511-S5991 | Janoshik | 2026-Q1 | 97.63 | 5.75 | 93.2 | Laboratory-retained | 1 | FAIL |
| AX-2025-021229 | Hexarelin | BCH | BCH-2501-B6879 | Medutest | 2025-Q2 | 97.87 | 5.32 | 107.1 | Supplier-supplied | 1 | FAIL |
| AX-2025-020928 | Thymalin | CPC | CPC-2501-V3057 | Janoshik | 2025-Q1 | N/A | 6.75 | — | Supplier-supplied | 0 | N/A |
| AX-2024-005367 | Semaglutide | CPC | CPC-2309-A2449 | VendorInvestigate | 2024-Q1 | 97.04 | 5.17 | 97.0 | Buyer-sourced | 1 | MARGINAL |